The nasal basal cell population shifts toward a diseased phenotype with impaired barrier formation capacity in allergic rhinitis.

Background: The integrity of the airway epithelium is guarded by the airway basal cells that serve as progenitor cells and restore wounds in case of injury. Basal cells are a heterogenous population, and specific changes in their behavior are associated with chronic barrier disruption-mechanisms that have not been studied in detail in allergic rhinitis (AR).
Objective: We aimed to study basal cell subtypes in AR and healthy controls.
Methods: Single-cell RNA sequencing (scRNA-Seq) of the nasal epithelium was performed on nonallergic and house dust mite-allergic AR patients to reveal basal cell diversity and to identify allergy-related alterations. Flow cytometry, immunofluorescence staining, and in vitro experiments using primary basal cells were performed to confirm phenotypic findings at the protein level and functionally.
Results: The scRNA-Seq, flow cytometry, and immunofluorescence staining revealed that basal cells are abundantly and heterogeneously present in the nasal epithelium, suggesting specialized subtypes. The total basal cell fraction within the epithelium in AR is increased compared to controls. scRNA-Seq demonstrated that potentially beneficial basal cells are missing in AR epithelium, while an activated population of allergy-associated basal cells is more dominantly present. Furthermore, our in vitro proliferation, wound healing assay and air-liquid interface cultures show that AR-associated basal cells have altered progenitor capacity compared to nonallergic basal cells.
Conclusions: The nasal basal cell population is abundant and diverse, and it shifts toward a diseased state in AR. The absence of potentially protective subtypes and the rise of a proinflammatory population suggest that basal cells are important players in maintaining epithelial barrier defects in AR.
Competing Interests: Disclosure statement The author’s laboratories are supported by grants from the research council of the KU Leuven (C14/18/086). T.W. is supported by a predoctoral grant of the Fund for Scientific Research Flanders (FWO), Belgium (11L8922N). B.S. received a postdoctoral fellowship from the Fund for Scientific Research Flanders (FWO), Belgium (12U6721N). K.M. received a junior postdoctoral fellowship from the Fund for Scientific Research Flanders (FWO), Belgium (12Z0622N). D.M.A.B. is a recipient of a senior clinical investigator grant of the Fund for Scientific Research Flanders (FWO), Belgium (1801014N) and from the Bijzonder Onderzoeksfonds—fundamenteel klinisch mandaat (BOF-FKM) of the KU Leuven (FKO CM23-FKO-02). Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.
(Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)